Safety and effectiveness of adalimumab in a clinical setting that reflects Canadian standard of care for the treatment of rheumatoid arthritis (RA): Results from the CanACT study

Peer Review reports

Original Submission
29 Jun 2011	Submitted	Original manuscript
15 Jul 2011	Reviewed	Reviewer Report - Bernhard Manger
24 Jul 2011	Reviewed	Reviewer Report - Rudolf Puchner
9 Sep 2011	Author responded	Author comments - Boulos Haraoui
Resubmission - Version 2
9 Sep 2011	Submitted	Manuscript version 2
16 Sep 2011	Author responded	Author comments - Boulos Haraoui
Resubmission - Version 3
16 Sep 2011	Submitted	Manuscript version 3
Resubmission - Version 4
	Submitted	Manuscript version 4
16 Nov 2011	Author responded	Author comments - Boulos Haraoui
Resubmission - Version 5
16 Nov 2011	Submitted	Manuscript version 5
Publishing
17 Nov 2011	Editorially accepted
17 Nov 2011	Article published	10.1186/1471-2474-12-261

Back to article page